Clinical Trial Update: Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ragweed MATAMPL, Pollinex-R, and placebo for efficacy and safety in ragweed allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Due to Ragweed Pollen
• Ragweed Allergy

Drugs mentioned

• Pollinex-R
• Ragweed MATAMPL

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 2 | Status: COMPLETED